位置:首页 > 蛋白库 > PLPP_MOUSE
PLPP_MOUSE
ID   PLPP_MOUSE              Reviewed;         292 AA.
AC   P60487;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 1.
DT   03-AUG-2022, entry version 146.
DE   RecName: Full=Chronophin {ECO:0000303|PubMed:24338473};
DE            EC=3.1.3.16 {ECO:0000250|UniProtKB:Q3ZBF9};
DE            EC=3.1.3.74 {ECO:0000269|PubMed:24338473, ECO:0000269|PubMed:24338687, ECO:0000269|PubMed:25783190};
DE   AltName: Full=Pyridoxal 5'-phosphate phosphatase {ECO:0000303|PubMed:24338473};
DE   AltName: Full=Pyridoxal phosphate phosphatase {ECO:0000303|PubMed:24338687};
DE            Short=PLP phosphatase {ECO:0000303|PubMed:24338687};
GN   Name=Pdxp {ECO:0000312|MGI:MGI:1919282};
GN   Synonyms=Cin {ECO:0000303|PubMed:24338687},
GN   Plp {ECO:0000303|PubMed:24338687}, Plpp;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=SWR/J; TISSUE=Brain;
RX   PubMed=14522954; DOI=10.1074/jbc.m309619200;
RA   Jang Y.M., Kim D.W., Kang T.-C., Won M.H., Baek N.-I., Moon B.J.,
RA   Choi S.Y., Kwon O.-S.;
RT   "Human pyridoxal phosphatase. Molecular cloning, functional expression, and
RT   tissue distribution.";
RL   J. Biol. Chem. 278:50040-50046(2003).
RN   [2]
RP   PROTEIN SEQUENCE OF 100-119 AND 141-154, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Hippocampus;
RA   Lubec G., Klug S.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 136-292.
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Liver, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [5] {ECO:0007744|PDB:4BX0, ECO:0007744|PDB:4BX2, ECO:0007744|PDB:4BX3}
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH MAGNESIUM AND
RP   BERYLLIUM TRIFLUORIDE, CATALYTIC ACTIVITY, FUNCTION, SUBUNIT,
RP   BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF 194-ALA-ALA-195, AND ACTIVE
RP   SITE.
RX   PubMed=24338687; DOI=10.1074/jbc.m113.536482;
RA   Kestler C., Knobloch G., Tessmer I., Jeanclos E., Schindelin H., Gohla A.;
RT   "Chronophin dimerization is required for proper positioning of its
RT   substrate specificity loop.";
RL   J. Biol. Chem. 289:3094-3103(2014).
RN   [6] {ECO:0007744|PDB:4BKM}
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 1-100 AND 208-233 IN COMPLEX WITH
RP   MAGNESIUM, TISSUE SPECIFICITY, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY
RP   REGULATION, AND FUNCTION.
RX   PubMed=24338473; DOI=10.1074/jbc.m113.503359;
RA   Seifried A., Knobloch G., Duraphe P.S., Segerer G., Manhard J.,
RA   Schindelin H., Schultz J., Gohla A.;
RT   "Evolutionary and structural analyses of the mammalian haloacid
RT   dehalogenase-type phosphatases AUM and chronophin provide insight into the
RT   basis of their different substrate specificities.";
RL   J. Biol. Chem. 289:3416-3431(2014).
RN   [7] {ECO:0007744|PDB:5AES}
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) IN COMPLEX WITH MAGNESIUM AND
RP   INHIBITOR, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   COFACTOR, SUBUNIT, AND ACTIVE SITE.
RX   PubMed=25783190; DOI=10.1016/j.bmc.2015.02.049;
RA   Knobloch G., Jabari N., Stadlbauer S., Schindelin H., Kohn M., Gohla A.;
RT   "Synthesis of hydrolysis-resistant pyridoxal 5'-phosphate analogs and their
RT   biochemical and X-ray crystallographic characterization with the pyridoxal
RT   phosphatase chronophin.";
RL   Bioorg. Med. Chem. 23:2819-2827(2015).
CC   -!- FUNCTION: Functions as a pyridoxal phosphate (PLP) phosphatase, which
CC       also catalyzes the dephosphorylation of pyridoxine 5'-phosphate (PNP)
CC       and pyridoxamine 5'-phosphate (PMP), with order of substrate preference
CC       PLP > PNP > PMP and therefore plays a role in vitamin B6 metabolism
CC       (PubMed:24338473, PubMed:24338687, PubMed:25783190). Also functions as
CC       a protein serine phosphatase that specifically dephosphorylates 'Ser-3'
CC       in proteins of the actin-depolymerizing factor (ADF)/cofilin family
CC       like CFL1 and DSTN. Thereby, regulates cofilin-dependent actin
CC       cytoskeleton reorganization, being required for normal progress through
CC       mitosis and normal cytokinesis. Does not dephosphorylate
CC       phosphothreonines in LIMK1. Does not dephosphorylate peptides
CC       containing phosphotyrosine (By similarity).
CC       {ECO:0000250|UniProtKB:Q96GD0, ECO:0000269|PubMed:24338473,
CC       ECO:0000269|PubMed:24338687, ECO:0000269|PubMed:25783190}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + pyridoxal 5'-phosphate = phosphate + pyridoxal;
CC         Xref=Rhea:RHEA:20533, ChEBI:CHEBI:15377, ChEBI:CHEBI:17310,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:597326; EC=3.1.3.74;
CC         Evidence={ECO:0000269|PubMed:24338473, ECO:0000269|PubMed:24338687,
CC         ECO:0000269|PubMed:25783190};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:20534;
CC         Evidence={ECO:0000305|PubMed:24338473};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + pyridoxine 5'-phosphate = phosphate + pyridoxine;
CC         Xref=Rhea:RHEA:25112, ChEBI:CHEBI:15377, ChEBI:CHEBI:16709,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58589; EC=3.1.3.74;
CC         Evidence={ECO:0000250|UniProtKB:Q96GD0};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25113;
CC         Evidence={ECO:0000250|UniProtKB:Q96GD0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=phosphate + pyridoxamine = H2O + pyridoxamine 5'-phosphate;
CC         Xref=Rhea:RHEA:25135, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57761, ChEBI:CHEBI:58451; EC=3.1.3.74;
CC         Evidence={ECO:0000250|UniProtKB:Q96GD0};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:25137;
CC         Evidence={ECO:0000250|UniProtKB:Q96GD0};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:83421; EC=3.1.3.16;
CC         Evidence={ECO:0000269|PubMed:24338473};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:20630;
CC         Evidence={ECO:0000269|PubMed:24338473};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:24338473, ECO:0000269|PubMed:24338687,
CC         ECO:0000269|PubMed:25783190};
CC       Note=Divalent metal ions. Mg(2+) is the most effective.
CC       {ECO:0000269|PubMed:24338473};
CC   -!- ACTIVITY REGULATION: Inhibited by beryllium trifluoride.
CC       {ECO:0000269|PubMed:24338473}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=36 uM for pyridoxal 5'-phosphate {ECO:0000269|PubMed:24338687,
CC         ECO:0000269|PubMed:25783190};
CC         Vmax=3.6 umol/min/mg enzyme with pyridoxal 5'-phosphate as substrate
CC         {ECO:0000269|PubMed:25783190};
CC         Note=kcat varies between 1.5 and 2.0 sec(-1) for the
CC         dephosphorylation of pyridoxal 5'-phosphate (at pH 7.4 and 22 degrees
CC         Celsius). {ECO:0000269|PubMed:24338687, ECO:0000269|PubMed:25783190};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:24338473,
CC       ECO:0000269|PubMed:24338687, ECO:0000269|PubMed:25783190}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q96GD0}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q96GD0}. Cell projection, ruffle membrane
CC       {ECO:0000250|UniProtKB:Q96GD0}; Peripheral membrane protein
CC       {ECO:0000250, ECO:0000250|UniProtKB:Q96GD0}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q96GD0}. Cell projection, lamellipodium membrane
CC       {ECO:0000250|UniProtKB:Q96GD0}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q96GD0}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q96GD0}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q96GD0}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q96GD0}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q96GD0}. Note=Colocalizes with the actin
CC       cytoskeleton in membrane ruffles and lamellipodia. Diffusely
CC       distributed throughout the cytosol during pro-metaphase and metaphase.
CC       Detected at the dynamic cell poles during telophase. Detected at the
CC       cleavage furrow and contractile ring during cytokinesis. Transiently
CC       detected at the plasma membrane in late stages of cytokinesis. Detected
CC       at the midbody. {ECO:0000250|UniProtKB:Q96GD0}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. highly expressed in brain (at protein
CC       level). {ECO:0000269|PubMed:24338473}.
CC   -!- SIMILARITY: Belongs to the HAD-like hydrolase superfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY366300; AAR12209.1; -; mRNA.
DR   EMBL; BC058388; AAH58388.1; -; mRNA.
DR   CCDS; CCDS27627.1; -.
DR   RefSeq; NP_064667.2; NM_020271.3.
DR   PDB; 4BKM; X-ray; 2.65 A; A/B/C/D=1-100, A/B/C/D=208-292.
DR   PDB; 4BX0; X-ray; 1.75 A; A=1-292.
DR   PDB; 4BX2; X-ray; 2.19 A; A/B=1-292.
DR   PDB; 4BX3; X-ray; 2.19 A; A/B=1-292.
DR   PDB; 5AES; X-ray; 2.75 A; A/B=1-292.
DR   PDBsum; 4BKM; -.
DR   PDBsum; 4BX0; -.
DR   PDBsum; 4BX2; -.
DR   PDBsum; 4BX3; -.
DR   PDBsum; 5AES; -.
DR   AlphaFoldDB; P60487; -.
DR   SMR; P60487; -.
DR   IntAct; P60487; 1.
DR   BindingDB; P60487; -.
DR   ChEMBL; CHEMBL3425392; -.
DR   iPTMnet; P60487; -.
DR   PhosphoSitePlus; P60487; -.
DR   SwissPalm; P60487; -.
DR   REPRODUCTION-2DPAGE; P60487; -.
DR   EPD; P60487; -.
DR   MaxQB; P60487; -.
DR   PaxDb; P60487; -.
DR   PeptideAtlas; P60487; -.
DR   PRIDE; P60487; -.
DR   ProteomicsDB; 289453; -.
DR   Antibodypedia; 34919; 109 antibodies from 27 providers.
DR   DNASU; 57028; -.
DR   Ensembl; ENSMUST00000089378; ENSMUSP00000086796; ENSMUSG00000116165.
DR   GeneID; 57028; -.
DR   KEGG; mmu:57028; -.
DR   UCSC; uc007wru.1; mouse.
DR   CTD; 57026; -.
DR   MGI; MGI:1919282; Pdxp.
DR   VEuPathDB; HostDB:ENSMUSG00000116165; -.
DR   GeneTree; ENSGT00940000162045; -.
DR   HOGENOM; CLU_043473_0_1_1; -.
DR   InParanoid; P60487; -.
DR   OMA; MDGVLIH; -.
DR   OrthoDB; 982374at2759; -.
DR   PhylomeDB; P60487; -.
DR   TreeFam; TF314344; -.
DR   BRENDA; 3.1.3.74; 3474.
DR   BioGRID-ORCS; 57028; 1 hit in 39 CRISPR screens.
DR   ChiTaRS; Pdxp; mouse.
DR   PRO; PR:P60487; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; P60487; protein.
DR   Bgee; ENSMUSG00000116165; Expressed in basal forebrain and 99 other tissues.
DR   Genevisible; P60487; MM.
DR   GO; GO:0015629; C:actin cytoskeleton; ISO:MGI.
DR   GO; GO:0005911; C:cell-cell junction; IDA:MGI.
DR   GO; GO:0032154; C:cleavage furrow; ISO:MGI.
DR   GO; GO:0070938; C:contractile ring; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISO:MGI.
DR   GO; GO:0031258; C:lamellipodium membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030496; C:midbody; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0032587; C:ruffle membrane; ISO:MGI.
DR   GO; GO:0043136; F:glycerol-3-phosphatase activity; IBA:GO_Central.
DR   GO; GO:0019838; F:growth factor binding; ISO:MGI.
DR   GO; GO:0031072; F:heat shock protein binding; ISO:MGI.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0017018; F:myosin phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016791; F:phosphatase activity; IBA:GO_Central.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0033883; F:pyridoxal phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0031247; P:actin rod assembly; ISO:MGI.
DR   GO; GO:0071318; P:cellular response to ATP; ISO:MGI.
DR   GO; GO:0016311; P:dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0030836; P:positive regulation of actin filament depolymerization; ISS:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0032361; P:pyridoxal phosphate catabolic process; IDA:UniProtKB.
DR   GO; GO:0032465; P:regulation of cytokinesis; ISS:UniProtKB.
DR   GO; GO:0007088; P:regulation of mitotic nuclear division; ISS:UniProtKB.
DR   Gene3D; 3.40.50.1000; -; 2.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR006357; HAD-SF_hydro_IIA.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR006349; PGP_euk.
DR   Pfam; PF13344; Hydrolase_6; 1.
DR   PIRSF; PIRSF000915; PGP-type_phosphatase; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR01460; HAD-SF-IIA; 1.
DR   TIGRFAMs; TIGR01452; PGP_euk; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cell projection; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Hydrolase; Magnesium; Membrane; Metal-binding;
KW   Pyridoxal phosphate; Reference proteome.
FT   CHAIN           1..292
FT                   /note="Chronophin"
FT                   /id="PRO_0000068838"
FT   ACT_SITE        25
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000305|PubMed:24338687,
FT                   ECO:0000305|PubMed:25783190, ECO:0007744|PDB:4BX2,
FT                   ECO:0007744|PDB:5AES"
FT   ACT_SITE        27
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:24338687,
FT                   ECO:0000305|PubMed:25783190, ECO:0007744|PDB:4BX2,
FT                   ECO:0007744|PDB:5AES"
FT   BINDING         25
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000269|PubMed:24338473,
FT                   ECO:0000269|PubMed:24338687, ECO:0000269|PubMed:25783190,
FT                   ECO:0007744|PDB:4BKM, ECO:0007744|PDB:4BX0,
FT                   ECO:0007744|PDB:4BX2, ECO:0007744|PDB:4BX3,
FT                   ECO:0007744|PDB:5AES"
FT   BINDING         27
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000269|PubMed:24338473,
FT                   ECO:0000269|PubMed:24338687, ECO:0000269|PubMed:25783190,
FT                   ECO:0007744|PDB:4BKM, ECO:0007744|PDB:4BX0,
FT                   ECO:0007744|PDB:4BX2, ECO:0007744|PDB:4BX3,
FT                   ECO:0007744|PDB:5AES"
FT   BINDING         58..60
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:24338687,
FT                   ECO:0000269|PubMed:25783190, ECO:0007744|PDB:4BX2,
FT                   ECO:0007744|PDB:5AES"
FT   BINDING         178
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:25783190,
FT                   ECO:0007744|PDB:5AES"
FT   BINDING         209
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:24338687,
FT                   ECO:0000269|PubMed:25783190, ECO:0007744|PDB:4BX2,
FT                   ECO:0007744|PDB:5AES"
FT   BINDING         234
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000269|PubMed:24338473,
FT                   ECO:0000269|PubMed:24338687, ECO:0000269|PubMed:25783190,
FT                   ECO:0007744|PDB:4BKM, ECO:0007744|PDB:4BX0,
FT                   ECO:0007744|PDB:4BX2, ECO:0007744|PDB:4BX3,
FT                   ECO:0007744|PDB:5AES"
FT   MUTAGEN         194..195
FT                   /note="AA->KK: Abolishes homodimerization. Strongly
FT                   decreases affinity for pyridoxal phosphate."
FT                   /evidence="ECO:0000269|PubMed:24338687"
FT   HELIX           9..18
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          20..25
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   TURN            27..29
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          30..32
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           40..49
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          53..58
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           65..74
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           82..84
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          85..87
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           88..99
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   TURN            104..106
FT                   /evidence="ECO:0007829|PDB:4BX2"
FT   STRAND          109..114
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           116..124
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          132..134
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          139..144
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           152..161
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          167..172
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          176..179
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          185..187
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           189..200
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           213..221
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           226..228
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          229..234
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   TURN            236..238
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           239..246
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          249..257
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           260..268
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           272..274
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   STRAND          277..282
FT                   /evidence="ECO:0007829|PDB:4BX0"
FT   HELIX           283..289
FT                   /evidence="ECO:0007829|PDB:4BX0"
SQ   SEQUENCE   292 AA;  31512 MW;  B5F1B2C7E71A585D CRC64;
     MARCERLRGA ALRDVLGQAQ GVLFDCDGVL WNGERIVPGA PELLQRLARA GKNTLFVSNN
     SRRARPELAL RFARLGFAGL RAEQLFSSAL CAARLLRQRL SGPPDASGAV FVLGGEGLRA
     ELRAAGLRLA GDPGEDPRVR AVLVGYDEQF SFSRLTEACA HLRDPDCLLV ATDRDPWHPL
     SDGSRTPGTG SLAAAVETAS GRQALVVGKP SPYMFQCITE DFSVDPARTL MVGDRLETDI
     LFGHRCGMTT VLTLTGVSSL EEAQAYLTAG QRDLVPHYYV ESIADLMEGL ED
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024